Logo image
Vasopressor agents without volume expansion as a safe alternative to venovenous bypass during cavaplasty liver transplantation
Journal article   Open access   Peer reviewed

Vasopressor agents without volume expansion as a safe alternative to venovenous bypass during cavaplasty liver transplantation

YOUMIN WU, Tanya L Oyos, Rou-Yee Chenhsu, Daniel A Katz, Johnny E Brian and Stephen C Rayhill
Transplantation, Vol.76(12), pp.1724-1728
2003
DOI: 10.1097/01.TP.0000100399.08640.E5
PMID: 14688523
url
https://doi.org/10.1097/01.TP.0000100399.08640.E5View
Published (Version of record) Open Access

Abstract

Background. Cavaplasty orthotopic liver transplantation (OLT) offers advantages for hepatectomy and implantation and eliminates the risk of outflow obstruction. However, it does require clamping of the cava. This study describes the use of a vasopressor without fluid expansion or venovenous bypass (VB) for hemodynamic control during the anhepatic phase. Methods. The cavaplasty OLT technique was used routinely. A vasopressor was administered if the mean arterial blood pressure (MAP) was less than 60 mm Hg after clamping of the cava. If the MAP did not reach 60 mm Hg after adjusting the dosage of the vasopressor, femoro-axillary VB would be used. VB was also indicated for preexisting cardiac disease or for massive hemorrhage from severe portal hypertension and extensive adhesions. Results. Among all the 121 adult cavaplasty OLTs, 33 were supported with VB and 50 received a vasopressor. The remaining 38 were excluded. However, baseline variables were well matched, except that preexisting cardiac disease was more frequent in the VB group. The median dosage of epinephrine was 0.07 μg/kg/min (range 0.01-0.6). The VB and vasopressor groups were similar in the reduction in mean MAP and the accumulation in arterial lactate upon clamping as well as in the central venous pressure upon unclamping. Postreperfusion hypotension was more frequent in the VB than in the vasopressor group (27.3% vs. 4.0%, P=0.006). There was no primary graft nonfunction or intraoperative right heart failure. One patient in the vasopressor group required postoperative temporary dialysis. Ninety-day patient and graft survival for the VB and vasopressor groups were 97.0% vs. 98.0% and 97.0% vs. 94.0%, respectively. Conclusion. Modest doses of vasopressor without volume expansion or VB can maintain hemodynamic stability during the anhepatic phase of cavaplasty OLT.
Biological and medical sciences Combined surgery. Multiple transplantations Medical sciences Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases

Details

Metrics

Logo image